Lalji K Gediya

Androgen receptor inactivation contributes to antitumor efficacy of 17α-hydroxylase/17,20-lyase inhibitor 3β-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer

Hong-Bin Fang, Pankaj Chopra, Zhiyong Guo, 2008, Molecular Cancer Therapeutics.

Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.

Pankaj Chopra, Zhiyong Guo, P. Chopra, 2005, Journal of medicinal chemistry.